Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer
Business Wire India $85M upfront financing, along with up to $255 million upon exercise of purchase warrants, is expected to…